Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis.

Shaodi MaWanying SuChenyu SunScott LoweZhen ZhouHaixia LiuGuangbo QuWeihang XiaPeng XieBirong WuJuan GaoLinya FengYehuan Sun

Published in: European journal of clinical pharmacology (2022)

This meta-analysis found that aspirin use was associated with a reduction in mortality in patients with COVID-19 and not with an increased risk of bleeding.

Keyphrases

cardiovascular events
low dose
systematic review
antiplatelet therapy
coronary artery disease
meta analyses
cardiovascular disease
atrial fibrillation
randomized controlled trial
type diabetes
percutaneous coronary intervention